Seliger B - Search Results

1

Predictive immunomonitoring -- the COST ENTIRE initiative.

Popadic D, Anegon I, Baeten D, Eibel H, Giese T, Marits P, Martinez-Caceres E, Mascart F, Nestle F, Pujol-Borrell R, Savic E, Scheibenbogen C, Seliger B, Thunberg S, Turina M, Villanova F, Winqvist O, Wikström AC. Popadic D, et al. Among authors: seliger b. Clin Immunol. 2013 Apr;147(1):23-26. doi: 10.1016/j.clim.2013.01.013. Epub 2013 Feb 8. Clin Immunol. 2013. PMID: 23454893 No abstract available.

2

Blood immune cell biomarkers in lung cancer.

Riemann D, Cwikowski M, Turzer S, Giese T, Grallert M, Schütte W, Seliger B. Riemann D, et al. Among authors: seliger b. Clin Exp Immunol. 2019 Feb;195(2):179-189. doi: 10.1111/cei.13219. Epub 2018 Nov 9. Clin Exp Immunol. 2019. PMID: 30246868 Free PMC article.

3

Comprehensive flow cytometric reference intervals of leukocyte subsets from six study centers across Europe.

Oras A, Quirant-Sanchez B, Popadic D, Thunberg S, Winqvist O, Heck S, Cwikowski M, Riemann D, Seliger B, Martinez Caceres E, Uibo R, Giese T. Oras A, et al. Among authors: seliger b. Clin Exp Immunol. 2020 Dec;202(3):363-378. doi: 10.1111/cei.13491. Epub 2020 Aug 3. Clin Exp Immunol. 2020. PMID: 32654132 Free PMC article. Clinical Trial.

4

Long-term freedom from recurrence in 2 stage IV melanoma patients following vaccination with tyrosinase peptides.

Scheibenbogen C, Nagorsen D, Seliger B, Schmittel A, Letsch A, Bauer S, Max N, Bock M, Atkins D, Thiel E, Keilholz U. Scheibenbogen C, et al. Among authors: seliger b. Int J Cancer. 2002 May 20;99(3):403-8. doi: 10.1002/ijc.10328. Int J Cancer. 2002. PMID: 11992409 Free article.

5

The dark side of dendritic cells: development and exploitation of tolerogenic activity that favor tumor outgrowth and immune escape.

Seliger B, Massa C. Seliger B, et al. Front Immunol. 2013 Dec 2;4:419. doi: 10.3389/fimmu.2013.00419. Front Immunol. 2013. PMID: 24348482 Free PMC article. Review.

6

Role of microRNAs on HLA-G expression in human tumors.

Seliger B. Seliger B. Hum Immunol. 2016 Sep;77(9):760-3. doi: 10.1016/j.humimm.2016.04.006. Epub 2016 Apr 30. Hum Immunol. 2016. PMID: 27142884 Review.

7

Combinatorial Approaches With Checkpoint Inhibitors to Enhance Anti-tumor Immunity.

Seliger B. Seliger B. Front Immunol. 2019 May 22;10:999. doi: 10.3389/fimmu.2019.00999. eCollection 2019. Front Immunol. 2019. PMID: 31178856 Free PMC article. Review.

8

The Role of the Lymphocyte Functional Crosstalk and Regulation in the Context of Checkpoint Inhibitor Treatment-Review.

Seliger B. Seliger B. Front Immunol. 2019 Sep 6;10:2043. doi: 10.3389/fimmu.2019.02043. eCollection 2019. Front Immunol. 2019. PMID: 31555274 Free PMC article. Review.

9

Modulation of Lymphocyte Functions in the Microenvironment by Tumor Oncogenic Pathways.

Seliger B, Massa C. Seliger B, et al. Front Immunol. 2022 May 19;13:883639. doi: 10.3389/fimmu.2022.883639. eCollection 2022. Front Immunol. 2022. PMID: 35663987 Free PMC article. Review.

10

"Tumor immunology meets oncology (TIMO) VI" from 7th to 8th of May 2010 in Halle, Germany.

Quandt D, Massa C, Seliger B. Quandt D, et al. Among authors: seliger b. Cancer Immunol Immunother. 2011 Feb;60(2):299-303. doi: 10.1007/s00262-010-0912-3. Epub 2010 Aug 28. Cancer Immunol Immunother. 2011. PMID: 20803010 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

388 results

Search Page